Reyderman L - Search Results

1

Administration of an antagonist of neurokinin receptors 1, 2, and 3 results in reproductive tract changes in beagle dogs, but not rats.

Losco PE, Leach MW, Sinha D, Davis P, Schmahai TJ, Nomier A, Kakkar T, Reyderman L, Lynch ME. Losco PE, et al. Among authors: reyderman l. Toxicol Pathol. 2007 Feb;35(2):310-22. doi: 10.1080/01926230701198766. Toxicol Pathol. 2007. PMID: 17366326

2

The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys.

Losco PE, Evans EW, Barat SA, Blackshear PE, Reyderman L, Fine JS, Bober LA, Anthes JC, Mirro EJ, Cuss FM. Losco PE, et al. Among authors: reyderman l. Toxicol Pathol. 2004 May-Jun;32(3):295-308. doi: 10.1080/01926230490431493. Toxicol Pathol. 2004. PMID: 15204971

3

Disposition and pharmacokinetics of temozolomide in rat.

Reyderman L, Statkevich P, Thonoor CM, Patrick J, Batra VK, Wirth M. Reyderman L, et al. Xenobiotica. 2004 May;34(5):487-500. doi: 10.1080/00498250410001685737. Xenobiotica. 2004. PMID: 15370964

4

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects.

Kosoglou T, Reyderman L, Tiessen RG, van Vliet AA, Fales RR, Keller R, Yang B, Cutler DL. Kosoglou T, et al. Among authors: reyderman l. Eur J Clin Pharmacol. 2012 Mar;68(3):249-58. doi: 10.1007/s00228-011-1120-6. Epub 2011 Sep 21. Eur J Clin Pharmacol. 2012. PMID: 21935705 Clinical Trial.

5

Assessment of a multiple-dose drug interaction between ezetimibe, a novel selective cholesterol absorption inhibitor and gemfibrozil.

Reyderman L, Kosoglou T, Statkevich P, Pember L, Boutros T, Maxwell SE, Affrime M, Batra V. Reyderman L, et al. Int J Clin Pharmacol Ther. 2004 Sep;42(9):512-8. doi: 10.5414/cpp42512. Int J Clin Pharmacol Ther. 2004. PMID: 15487810 Clinical Trial.

6

Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma.

Yang L, Clement RP, Kantesaria B, Reyderman L, Beaudry F, Grandmaison C, Di Donato L, Masse R, Rudewicz PJ. Yang L, et al. Among authors: reyderman l. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 25;792(2):229-40. doi: 10.1016/s1570-0232(03)00267-8. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12860030

7

Disposition of loratadine in healthy volunteers.

Ramanathan R, Reyderman L, Kulmatycki K, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE. Ramanathan R, et al. Among authors: reyderman l. Xenobiotica. 2007 Jul;37(7):753-69. doi: 10.1080/00498250701463317. Xenobiotica. 2007. PMID: 17620221

8

The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.

Reyderman L, Kosoglou T, Cutler DL, Maxwell S, Statkevich P. Reyderman L, et al. Curr Med Res Opin. 2005 Aug;21(8):1171-9. doi: 10.1185/030079905X46386. Curr Med Res Opin. 2005. PMID: 16083526 Clinical Trial.

9

Disposition of desloratadine in healthy volunteers.

Ramanathan R, Reyderman L, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE. Ramanathan R, et al. Among authors: reyderman l. Xenobiotica. 2007 Jul;37(7):770-87. doi: 10.1080/00498250701463325. Xenobiotica. 2007. PMID: 17620222

10

Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers.

Reyderman L, Kosoglou T, Boutros T, Seiberling M, Statkevich P. Reyderman L, et al. Curr Med Res Opin. 2004 Sep;20(9):1493-500. doi: 10.1185/030079904X2547. Curr Med Res Opin. 2004. PMID: 15383199 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters